Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract

Cytotherapy

Volumn 15, Issue 9, 2013, Pages 1164-1173

  Wang, Zhenfei ^a   Yue, Yongli ^a   Han, Pengyong ^a   Sa, Rula ^a   Ren, Xiaolv ^a   Wang, Jie ^a   Bai, Haidong ^a   Yu, Haiquan ^a  

^a INNER MONGOLIA UNIVERSITY   (China)

Author keywords

Bovine oocyte extract; Epigenetic modification; Remodeling; Tumor suppressor gene

Indexed keywords

BOVINE OOCYTE EXTRACT; CELL EXTRACT; MESSENGER RNA; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; UVOMORULIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CDH1 GENE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL STRAIN H460; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DNA SEQUENCE; EPIGENETIC MODIFICATION; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC REGULATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RUNX3 GENE; TRANSCRIPTION REGULATION; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION;

BOVINAE;

BOVINE OOCYTE EXTRACT; EPIGENETIC MODIFICATION; REMODELING; TUMOR SUPPRESSOR GENE;

ANIMALS; CADHERINS; CATTLE; CELL EXTRACTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; NEOPLASM INVASIVENESS; OOCYTES; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84881093171     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.05.001     Document Type: Article

References (28)

1. Huang Y.W., Kuo C.T., Stoner K., Huang T.H., Wang L.S. An overview of epigenetics and chemoprevention. FEBS Lett 2011, 585:2129-2136.
2. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
3. Yoo C.B., Jones P.A. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 2006, 5:37-50.
4. Hamm C.A., Xie H., Costa F.F., Vanin E.F., Seftor E.A., Sredni S.T., et al. Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity. PloS One 2009, 4:e8340.
5. Daskalos A., Nikolaidis G., Xinarianos G., Savvari P., Cassidy A., Zakopoulou R., et al. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer 2009, 124:81-87.
6. Kong D., Ahmad A., Bao B., Li Y., Banerjee S., Sarkar F.H. Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells. PloS One 2012, 7:e45045.
7. Debeb G., Lacerda L., Xu W., Larson R., Solley T., Atkinson R., et al. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling. Stem Cells 2012, 30:2366-2377.
8. Wu S.C., Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 2010, 11:607-620.
9. Dean W., Santos F., Stojkovic M., Zakhartchenko V., Walter J., Wolf E., et al. Conservation of methylation reprogramming in mammalian development: aberrant reprogramming in cloned embryos. Proc Natl Acad Sci U S A 2001, 98:13734-13738.
10. Bian Y., Alberio R., Allegrucci C., Campbell K.H., Johnson A.D. Epigenetic marks in somatic chromatin are remodelled to resemble pluripotent nuclei by amphibian oocyte extracts. Epigenetics 2009, 4:194-202.
11. Ganier O., Bocquet S., Peiffer I., Brochard V., Arnaud P., Puy A., et al. Synergic reprogramming of mammalian cells by combined exposure to mitotic Xenopus egg extracts and transcription factors. Proc Natl Acad Sci U S A 2011, 108:17331-17336.
12. Miyamoto K., Tsukiyama T., Yang Y., Li N., Minami N., Yamada M., et al. Cell-free extracts from mammalian oocytes partially induce nuclear reprogramming in somatic cells. Biol Reprod 2009, 80:935-943.
13. Miyamoto K., Nagai K., Kitamura N., Nishikawa T., Ikegami H., Binh N.T., et al. Identification and characterization of an oocyte factor required for development of porcine nuclear transfer embryos. Proc Natl Acad Sci U S A 2011, 108:7040-7045.
14. Ostrup O., Hyttel P., Klaerke D.A., Collas P. Remodeling of ribosomal genes in somatic cells by Xenopus egg extract. Biochem Biophys Res Commun 2011, 412:487-493.
15. Li Q.L., Kim H.R., Kim W.J., Choi J.K., Hee Lee Y., Kim H.M., et al. Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer. Biochem Biophys Res Commun 2004, 314:223-228.
16. Reinhold W.C., Reimers M.A., Lorenzi P., Ho J., Shankavaram U.T., Ziegler M.S., et al. Multifactorial regulation of E-cadherin expression: an integrative study. Mol Cancer Ther 2010, 9:1-16.
17. Morgan H.D., Dean W., Coker H.A., Reik W., Petersen-Mahrt S.K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: implications for epigenetic reprogramming. JBiol Chem 2004, 279:52353-52360.
18. Lee G., Wolff E., Miller J.H. Mutagenicity of the cytidine analog zebularine in Escherichia coli. DNA Repair 2004, 3:155-161.
19. Diaz A., Leon K. Therapeutic approaches to target cancer stem cells. Cancers 2011, 3:3331-3352.
20. McGarvey K.M., Fahrner J.A., Greene E., Martens J., Jenuwein T., Baylin S.B. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res 2006, 66:3541-3549.
21. Cameron E.E., Bachman K.E., Myöhänen S., Herman J.G., Baylin S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999, 21:103-107.
22. Tabolacci E., De Pascalis I., Accadia M., Terracciano A., Moscato U., Chiurazzi P., et al. Modest reactivation of the mutant FMR1 gene by valproic acid is accompanied by histone modifications but not DNA demethylation. Pharmacogenet Genomics 2008, 18:738-741.
23. Prince H.M., Bishton M.J., Harrison S.J. Clinical studies of histonedeacetylase inhibitors. Clin Cancer Res 2009, 15:3958-3969.
24. Chuang L.S., Ito Y. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors. Oncogene 2010, 29:2605-2615.
25. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson Å., Beer S., Mandl S., et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 2004, 431:1112-1117.
26. Berx G., Cleton-Jansen A., Nollet F., De Leeuw W., Van de Vijver M., Cornelisse C., et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995, 14:6107-6115.
27. Van Roy F., Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008, 65:3756-3788.
28. Eipper-Mains J.E., Kiraly D.D., Palakodeti D., Mains R.E., Eipper B.A., Graveley B. microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs. RNA 2011, 17:1529-1543.